Daily Science Journal (Feb. 11, 2008) — The U.S. Food and Drug Administration has notified the public that Botox and Botox Cosmetic (Botulinum toxin Type A) and Myobloc (Botulinum toxin Type B) have been linked in some cases to adverse reactions, including respiratory failure and death, following treatment of a variety of conditions using a wide range of doses.

In an early communication based on the FDA's ongoing safety review, the agency said the reactions may be related to overdosing. There is no evidence that these reactions are related to any defect in the products.


The adverse effects were found in FDA-approved and nonapproved usages. The most severe adverse effects were found in children treated for spasticity in their limbs associated with cerebral palsy. Treatment of spasticity is not an FDA-approved use of botulism toxins in children or adults.

The adverse reactions appear to be related to the spread of the toxin to areas distant from the site of injection, and mimic symptoms of botulism, which may include difficulty swallowing, weakness and breathing problems.

The FDA is not advising health care professionals to discontinue prescribing these products.

The agency is currently reviewing safety data from clinical studies submitted by the drugs' manufacturers, as well as post-marketing adverse event reports and medical literature. After completing a review of the data, the FDA will communicate to the public its conclusions, resulting recommendations, and any regulatory actions.

Adapted from materials provided by US Food And Drug Administration.



Read the rest of this entry »

Daily Science Journal (Feb. 11, 2008) — John Wesley Powell wrote in 1895: “...what a conflict of water and fire there must have been [in western Grand Canyon]! Just imagine a river of molten rock running down over a river of melted snow.”

Toroweap Point in Grand Canyon national park. (Credit: iStockphoto/Natalia Bratslavsky)

Over 110 years later, a synthesis of new and existing dates on these lava flows shows that many are significantly younger than initially thought and all are less than 725 thousand years old. The geochronology data indicates four major episodes when lava flows either erupted into the canyon or flowed over the rim into it: 725-475 thousand years ago (ka), 400-275 ka, 225-150 ka, and 150-75 ka.

These flows formed lava dams in western Grand Canyon that had dramatic impact on the Colorado River.


This paper* presents light detection and ranging (lidar) data to establish the elevations of the tops and bottoms of basalt flow remnants along the river corridor. These data show the original extent of now-dissected intra-canyon flows and aid in correlation of flow remnants.

From 725 to 475 ka, volcanism built a high edifice within Grand Canyon in the area of the Toroweap fault, with dike-cored cinder cones on both rims and within the canyon itself. These large-volume eruptions helped drive the far-traveled basalt flows which flowed down-canyon over 120 km. A second episode of volcanism, from 400 to 275 ka, built a 215-m-high dam along the Hurricane fault, about 15 km downstream.

The ca. 200 and 100 ka flows (previously mapped as Gray Ledge) were smaller flows and lava cascades that entered the canyon from the north rim between the Toroweap and Hurricane faults.

The combined results suggest a new model for the spatial and temporal distribution of volcanism in Grand Canyon in which composite lava dams and edifices were generally leaky in proximal areas.

Available data suggest that the demise of volcanic edifices may have involved either large outburst-flood events or normal fluvial deposition at times when the river was established on top of basalt flows. These data highlight complex interactions of volcanism and fluvial processes in this classic locality.

This research, authored by Ryan Crow (University of New Mexico) et al. was published in the February issue of Geosphere, published by the Geological Society of America.

Adapted from materials provided by Geological Society of America.



Read the rest of this entry »

Daily Science Journal (Feb. 10, 2008) — For Kansas State University physics professor Uwe Thumm, confirmation of a theory about the behavior of small molecules became music to his ears -- literally. He and colleagues in Heidelberg, Germany, have shown how a hydrogen molecule responds to laser pulses by using the changing musical chord created by the molecule's vibrational motion.

Researchers in Heidelberg visualized the development over time of molecular resonance. The distance between the two nuclei (R) in the heavy hydrogen (deuterium) ion D2+ is plotted against the time. After approximately 100 femtoseconds, the wave packet, i.e. the location of the nuclei, starts to become hazy, after 400 femtoseconds there is a "revival" and the wave packet is put back together again. (Credit: Max Planck Institute for Nuclear Physics)

Thumm is a member of K-State's J.R. Macdonald Laboratory, where he is among several researchers who work on the properties and behavior of atoms and small molecules.

For decades, researchers had used the Macdonald Laboratory to make atoms and molecules collide with particles. Thumm said much of what scientists know about atoms and molecules is based on such collision experiments. To predict and explain what happens in these collisions, a large group of experimental physicists works closely with Thumm and two other theorists. The theorists use computers, make models and crunch numbers with the hope of producing results that are compatible with what experiments show.


Thanks to improvements in laser technology, around 1999 the Macdonald Laboratory researchers realized that they could transfer a lot of their expertise in atomic collisions to study in detail what happens when atoms and molecules get irradiated by very intense laser light. The new laser systems in the laboratory offer some advantages over the big particle accelerators, Thumm said. The laser pulses offer more control and can be made so short that the researchers now routinely observe the motion of nuclei inside small molecules in time. In addition, the laser pulses' peak intensity is enormous and would equal all of the sun's light focused onto a small spot of the size of a postage stamp or smaller.

Motivated by these opportunities, Thumm and his colleagues became curious about figuring out what would happen if the smallest and simplest molecule, hydrogen, were exposed to such ultra short and intense laser pulses. Together with his postdoctoral collaborator Bernold Feuerstein, Thumm developed a model and did calculations to determine how laser pulses influence the motion of the two protons in the hydrogen molecule.

"The short answer is that the laser pulse either makes the molecules vibrate more violently or blows them apart," Thumm said. He said this wasn't surprising because in the hydrogen molecule, two protons are connected by two electrons that function like a spring. When hit with the laser pulses, the protons oscillate back and forth.

Although this model may be easy to imagine on a large scale, Thumm said particles behave differently at the quantum level. This means that determining the locations of these oscillating protons isn't easy. Thumm described determining the protons' movements after being hit with the laser like what happens if you drop a marble in a bathtub. Looking at the circular ripples of water in the center of the tub, it's pretty easy to tell where the marble was dropped in. But when those ripples bounce off the sides of the tub, the wave pattern changes shape, and it becomes harder to tell where the marble was dropped. The wave gets delocalized. Thumm said the same thing happens to the protons not in a matter of seconds, but in a matter of femtoseconds -- that's a billionth of a millionth of a second. After about 60 femtoseconds, it's impossible to tell where the protons are.

"You quickly loose track of what the distance between the two protons is," Thumm said." All you can say is that they have a certain likelihood of being at a certain distance. This is in agreement with the bathtub experiment: Seconds after the marble was dropped, you can't tell where exactly it plunged in."

But things work differently at the quantum level, and the researchers were surprised that about 600 femtoseconds after being hit with the laser, the distance between the protons again becomes well defined. "We call this a revival of the original motion of the protons," Thumm said. "It's not going to happen in the bathtub, but it happens at the quantum level."

Thumm and Feuerstein published their theoretical prediction in 2003. Thumm said that they were pleasantly surprised when experiments at the Max-Planck Institute in Heidelberg, Germany, in 2006 confirmed the revival described in their model. "The agreement between the new experiments and our model was almost perfect and exceeded our expectations," Thumm said.

Feuerstein had since moved to Heidelberg, where he and his group of researchers continued to collaborate with Thumm's group at K-State. Excited about the success of their model, they began to analyze the molecule's vibrational motion by breaking it down into its various frequencies. Each frequency being like a note in a chord, the frequencies told researchers how the protons were behaving. However, the frequency of these molecular vibrations is way above the audible range. The two researchers share an interest in music and had collaborated musically before. So when it came time to illustrate the revival, they decided the best way to do it was to scale the frequencies down to 1,000 Hertz, which is in the range at which the human ear hears best. "This way you can listen to the vibrations and hear the revival. In the same way sound is analyzed and decomposed, we decomposed the vibration with regard to the frequencies," Thumm said. Their result, a changing musical chord coupled with a movie illustrating the protons' vibrations can be heard and viewed at http://www.mpg.de/video/FilmundoAudio-KdM.wmv

Thumm said researchers hope to be able to do the same thing for more complex molecules like water or methane. Just as a C Major chord sounds different from a d minor chord, Thumm said other molecules also would have their own unique sound. Thumm and Feuerstein's most recent work was first published last fall in the Physical Review Letters. Their research was supported by the National Science Foundation, the U.S. Department of Energy and the Max-Planck Society. Thumm said such basic research supports the long-term goal of applying lasers to steer chemical reactions. The hope is to largely increase the efficiency of chemical reactions by enhancing desired reaction pathways with lasers, he said.

Adapted from materials provided by Kansas State University.



Read the rest of this entry »

Daily Science Journal (Feb. 10, 2008) — People taking a widely used group of drugs known as calcium channel blockers to treat high blood pressure also appear to be cutting their risk of Parkinson's disease, according to a new study.

The study involved 7,374 men and women over age 40. Half of the group had Parkinson's disease; the other half did not have Parkinson's disease. Among both groups, nearly half used high blood pressure medications, such as calcium channel blockers, ACE inhibitors, AT II antagonists and beta blockers.


The study found people who were currently long-term users of calcium channel blockers to treat high blood pressure lowered their risk of Parkinson's disease by 23 percent compared to people who didn't take the drugs. There was no such effect among people taking ACE inhibitors, AT II antagonists and beta blockers.

"Long-term use of calcium channel blockers was associated with a reduced risk of developing Parkinson's disease while no such association was seen for other high blood pressure medicines," said study author Christoph R. Meier, PhD, MSc, with University Hospital Basel in Switzerland.

Meier says more research is needed to determine why calcium channel blockers appear to protect against Parkinson's disease, whether this is indeed a causal association, and why the other high blood pressure medications do not offer a reduced risk.

This research was published in the February 6, 2008, online issue of Neurology®, the medical journal of the American Academy of Neurology.

Adapted from materials provided by American Academy of Neurology.



Read the rest of this entry »

Daily Science Journal (Feb. 10, 2008) — Teenage fathers are at increased risk of having babies born with birth problems ranging from pre-term delivery or low birth weight, through to death in or near to the time of delivery, according to new research.*

In contrast, the study also found that older fathers, aged 40 and over, were not at increased risk of having babies affected by these problems. The results were independent of the age of the mother or other maternal factors that might be expected to have an impact on birth outcomes.

The research is the largest study on the effects of paternal age on adverse birth outcomes. The researchers, from the Ottawa Health Research Institute, Canada, used data from the National Center for Health Statistics for nearly all the births (99%) in the USA between 1995-2000 -- a cohort of more than 23.6 million births. From these, they looked at 2,614,966 singleton babies born live to married women without previous childbearing histories, aged between 20-29, where there was complete information on paternal age, race, maternal education, prenatal care, and gestational and birth weight.


They chose women aged between 20-29 because they were the least likely to be affected by fertility problems, some of which can have an impact on birth outcomes. Since it is already known that fathers aged between 20-29 have the lowest risk of adverse birth outcomes, the researchers used this age group (the reference group) to compare all the other age groups against.

Compared to the reference group and after adjusting for confounding factors (such as race, education, smoking and alcohol drinking during pregnancy, adequacy of prenatal care and the sex of the baby), babies born to teenage fathers (aged less than 20) were more likely to be born early (a 15% increased risk), have low birth weight (13% increased risk), be small for gestational age (17% increased risk), have a low Apgar score (13% increased risk) or to die within the first four weeks after birth (22% increased risk) or to die in the period from four weeks to one year after birth (41% increased risk), although in all cases the absolute risk of death remained less than 0.5% . Fathers aged 40 or over did not have an increased risk of these adverse birth outcomes.

One of the authors of the study, Professor Shi Wu Wen, senior scientist at the Ottawa Health Research Institute and professor at the University of Ottawa, said: "Our study indicated that being a teenage father was an independent risk factor for adverse birth outcomes, whereas advanced paternal age was not. The paternal influence of younger fathers on adverse birth outcomes clearly warrants further investigation, and may lead to a deeper understanding of the causes of such outcomes.

"Although the increased relative risks for most outcomes were small, the magnitude of the risks to society could be huge, given the number of births worldwide, if the increases we found are truly attributable to paternal age."

The study looked at babies born to fathers in seven age groups, from teenagers through to those aged 50 and over, and Prof Wen said this, together with the large size of the study and the limited age range of the mothers, meant that the findings were unlikely to be affected by chance or confounding factors. However, there was no information available on the socio-economic status and lifestyle of the fathers, and this could have an impact.

"The mechanisms by which being a teenage father may contribute to an increased risk of adverse birth outcomes are not clear," said Prof Wen. "Both biological and socio-economic status might play some roles in the observed findings."

Previous studies have shown that younger men can have lower sperm counts, semen volume, total numbers of spermatozoa and percentage of motile sperm. Immature sperm may be associated with adverse birth outcomes, possibly as a result of the abnormal formation of the placenta in the uterus (placentation).

"It is biologically plausible that paternal age might play a role in the risk of adverse birth outcomes associated with abnormal placentation," said Prof Wen.

However, there are also possible social explanations too. "Young fathers are more likely to come from economically disadvantaged families and to have lower educational attainment. Socio-economic factors such as education and occupation are known to be associated with a number of health outcomes. People from less affluent backgrounds are less likely to utilise prenatal care services, which is associated with an increased risk of adverse birth outcomes," explained Prof Wen.

Other social factors that might play a role, perhaps by adversely affecting the mother's health, include domestic violence, lack of financial or emotional support, paternal illicit drug use, smoking and alcohol drinking. "These are more prevalent in teenage fathers, and previous studies have found associations between paternal smoking and alcohol and adverse reproductive outcomes," he said.

Of the finding that older fathers were not more likely to have babies affected by adverse birth outcomes, Prof Wen said: "In our present study, we did not find an association between older fathers and the increased risk of adverse birth outcomes. We could not exclude the possibility that older fathers who married women aged 20-29 years without childbearing history might have a higher socioeconomic status than our control groups. The advantaged socioeconomic conditions might offset some biological risk of adverse birth outcomes associated with older fathers."

Prof Wen said he and his colleagues were planning a pre-conception study to look at various paternal and maternal factors that might have an effect on the health of babies, including paternal age.

*Paternal age and adverse birth outcomes: teenager or 40+, who is at risk? Human Reproduction. doi:10.1093/humrep/dem403.

Adapted from materials provided by European Society for Human Reproduction and Embryology, via EurekAlert!, a service of AAAS.



Read the rest of this entry »

Daily Science Journal (Feb. 10, 2008) — An international clinical trial has found that acyclovir, a common medication for treating herpes simplex virus-2 (HSV-2), the most common cause of genital herpes, does not reduce the risk of HIV infection when taken by people infected with HSV-2. Multiple studies have shown that people with HSV-2 have a higher risk of acquiring HIV. Researchers had hoped that acyclovir's ability to suppress the herpes virus, and its associated genital sores and breaks in the skin, could cut down on the likelihood of HIV being transmitted to a person with HSV-2 during sexual intercourse.

The Phase III clinical trial was led by the University of Washington in Seattle, in coordination with the HIV Prevention Trials Network, an international consortium funded by the National Institute of Allergy and Infectious Diseases (NIAID) in the National Institutes of Health. The findings were presented this week at the Conference on Retroviruses and Opportunistic Infections in Boston.


"The study was successful in answering the question of whether acyclovir could cut down on the risk of HIV acquisition for people infected with HSV-2," explained Dr. Connie Celum, the leader of the study and a UW professor of global health and medicine in the Division of Allergy and Infectious Disease and director of the International Clinical Research Center in the UW Department of Global Health. "We were hopeful that acyclovir would help reduce HIV acquisition in people with HSV-2. Though the study did not find that acyclovir helped with HIV acquisition, we did find that it reduced genital ulcers associated with HSV-2. Now we need to continue our research on the mechanisms through which HSV-2 acts as a risk factor for HIV, and how we might be able to use that knowledge to reduce the spread of HIV."

HSV-2 is one of the most common sexually transmitted infections worldwide and is especially prevalent in areas with high rates of HIV infection. Most people who are infected with HSV-2 do not know they have the virus because symptoms can be mild or absent. In some infected individuals, the virus can produce recurring genital herpes, a condition characterized by sores and breaks in the skin of the genital region. An active HSV-2 infection also attracts immune-system cells called CD-4 T-cells to the genital region, and HIV easily attaches to this type of cell. Multiple studies have shown that people with HSV-2 have a two-fold increase in their risk of acquiring HIV.

This study followed up on those results to test the theory that suppressing HSV-2 could cut down on HIV acquisition. It was launched in 2003, and with nine study sites in Peru, South Africa, Zambia, Zimbabwe, and the United States, it was the largest study yet of herpes suppression. There were 3,277 people with HSV-2 initially enrolled in the study, 105 people excluded, and 3,172 people included in the final analysis. Volunteers in Peru and the United States were HSV-2-infected men who have sex with men, and volunteers in Africa were HSV-2-infected women.

Half of the participants were randomly assigned to receive either a placebo or a standard daily dose of acyclovir, 400 mg twice a day. The study was double-blinded, meaning that neither participants nor care providers knew which treatment the participants were receiving. Both the placebo and treatment groups received standard HIV-prevention treatment, which includes being supplied with condoms and given extensive counseling on how to reduce the risk of HIV infection.

Researchers found that there was a 3.9 percent HIV incidence rate, a total of 75 cases, in participants who received acyclovir suppression, and a 3.3 percent HIV incidence rate, or 64 cases, in the placebo group. The difference between the groups was not statistically significant. The acyclovir treatment did succeed in reducing genital ulcers -- participants in the treatment group had a 37 percent reduction in genital ulcer incidence, and a significantly lower proportion of ulcers due to HSV-2.

"The study answered the scientific questions it was designed to answer," says Dr. Anna Wald, a UW professor of medicine and epidemiology who also helped lead the study. "The sites were able to recruit and retain a large number of volunteers, who maintained a high level of adherence to the twice-daily drug regimen. While we are disappointed with the results, the study was well-conducted and provides a clear answer about using acyclovir to reduce the risk of becoming HIV-infected."

The study participants have been informed of the findings and are being counseled on the continued need to avoid HIV exposure. Volunteers who became infected with HIV during the trial have been referred for appropriate medical care and treatment.

The study was supported by NIAID, and the acyclovir was supplied by GlaxoSmithKline. The HIV Prevention Trials Network is led by Family Health International, the network laboratory of Johns Hopkins University, and the Statistical Center for HIV/AIDS Research and Prevention at the Fred Hutchinson Cancer Research Center in Seattle. The study was conducted at the following sites: Iquitos, Lima and Pucallpa, in Peru; Johannesburg, South Africa; New York, San Francisco, and Seattle, in the United States; Lusaka, Zambia; and Harare, Zimbabwe.

Adapted from materials provided by University Of Washington.



Read the rest of this entry »

Daily Science Journal (Feb. 9, 2008) — Natural flyers like birds, bats and insects outperform man-made aircraft in aerobatics and efficiency. University of Michigan engineers are studying these animals as a step toward designing flapping-wing planes with wingspans smaller than a deck of playing cards.

Flapping flight is inherently unsteady, but that's why it works so well. Birds, bats and insects fly in a messy environment full of gusts traveling at speeds similar to their own. Yet they can react almost instantaneously and adapt with their flexible wings. (Credit: iStockphoto/Steve Byland)

A Blackbird jet flying nearly 2,000 miles per hour covers 32 body lengths per second. But a common pigeon flying at 50 miles per hour covers 75. The roll rate of the aerobatic A-4 Skyhawk plane is about 720 degrees per second. The roll rate of a barn swallow exceeds 5,000 degrees per second.


Select military aircraft can withstand gravitational forces of 8-10 G. Many birds routinely experience positive G-forces greater than 10 G and up to 14 G.

“Natural flyers obviously have some highly varied mechanical properties that we really have not incorporated in engineering,” said Wei Shyy, chair of the Aerospace Engineering department and an author of the new book “The Aerodynamics of Low Reynolds Number Flyers.”

“They’re not only lighter, but also have much more adaptive structures as well as capabilities of integrating aerodynamics with wing and body shapes, which change all the time,” Shyy said. “Natural flyers have outstanding capabilities to remain airborne through wind gusts, rain, and snow.” Shyy photographs birds to help him understand their aerodynamics.

Pressure generated during flight cause the flapping wings to deform, he explained. In turn, the deformed wing tells the air that the wing shape is different than it appears in still air. If appropriately handled, this phenomenon can delay stall, enhance stability and increase thrust.

Flapping flight is inherently unsteady, but that’s why it works so well. Birds, bats and insects fly in a messy environment full of gusts traveling at speeds similar to their own. Yet they can react almost instantaneously and adapt with their flexible wings.

Shyy and his colleagues have several grants from the Air Force totaling more than $1 million a year to research small flapping wing aircraft. Such aircraft would fly slower than their fixed wing counterparts, and more importantly, they would be able to hover and possibly perch in order to monitor the environment or a hostile area. Shyy’s current focus is on the aerodynamics of flexible wings related to micro air vehicles with wingspans between 1 and 3 inches.

“These days, if you want to design a flapping wing vehicle, you could build one with trial and error, but in a controlled environment with no wind gusts,” Shyy said. “We are trying to figure out how to design a vehicle that can perform a mission in an uncertain environment. When the wind blows, how do they stay on course?”

A dragonfly, Shyy says, has remarkable resilience to wind, considering how light it is. The professor chalks that up to its wing structure and flight control. But the details are still questions.

“We’re really just at the beginning of this,” Shyy said.

Shyy is the Clarence L. "Kelly" Johnson Collegiate Professor of Aerospace Engineering. Other authors of the book, “Aerodynamics of Low Reynolds Number Flyers” are: U-M research scientists Yongsheng Lian, Jian Tang and Dragos Viieru, and Hao Liu, professor of Biomechanical Engineering at Chiba University in Japan.

Other collaborators on this research include professors Luis Bernal, Carlos Cesnik and Peretz Friedmann of the University of Michigan; Hao Liu of Chiba University in Japan; Peter Ifju, Rick Lind and Larry Ukeiley of University of Florida, and Sean Humbert of University of Maryland.

Adapted from materials provided by University of Michigan.



Read the rest of this entry »

Daily Science Journal (Feb. 9, 2008) — Babies recently treated with infant personal care products such as lotion, shampoo, and powder, were more likely to have manmade chemicals called phthalates in their urine than other babies, according to University of Washington and Seattle Children's Hospital Research Institute study appearing in the February issue of the journal Pediatrics. Phthalates (pronounced "thah-lates") are added to many personal care and cosmetic products, as well many common household plastic and vinyl products, and some studies suggest they may affect reproductive development in humans.

Babies recently treated with infant personal care products such as lotion, shampoo, and powder, were more likely to have manmade chemicals called phthalates in their urine than other babies. (Credit: iStockphoto/Roman Barelko)

Animal-based studies of phthalates have found that the synthetic chemicals can harm reproductive system development, and studies in humans have found that prenatal exposure or exposure through breast milk can alter hormone concentrations. Early-childhood exposure has not been extensively studied, so additional research is needed to determine if phthalate exposure can indeed cause reproductive development problems or other adverse effects in infants.


In this study, the researchers set out to see if use of personal care products was associated with urine phthalate concentrations. To accomplish this, they collected urine samples from 163 infants aged 2 months to 28 months, and measured the levels of nine different phthalates in those urine samples. They also had the babies' mothers fill out questionnaires on their use of infant personal care products in the past 24 hours.

When they cross-referenced the data, they found that the use of baby powder, lotion, and shampoo were each strongly associated with higher phthalate levels in the urine. The use of baby wipes and diaper cream were not strongly associated with increased levels of phthalates. The scientists also found that every baby had detectable levels of at least one phthalate in their urine, and about 81 percent of the infants had detectable levels of seven or more phthalates. Babies who were 8 months old or younger had stronger associations between product use and phthalate concentrations, as did babies whose mothers used more infant personal care products.

"We found that infant exposure to phthalates is widespread, and that exposure to personal care products applied onto the skin may be an important source," said the study's lead author, Sheela Sathyanarayana, an acting assistant professor of pediatrics at the UW School of Medicine and a researcher with Seattle Children's Hospital Research Institute. "This is troubling, because phthalate exposure in early childhood has been associated with altered hormone concentrations as well as increased allergies, runny nose, and eczema. Babies may be more at risk than children or adults because their reproductive, endocrine, and immune systems are still developing."

Parents who want to decrease their baby's exposure to phthalates should limit the amount of baby care products used on the infant, and apply lotions or powders only if medically indicated. Since phthalates are also found in many household plastic products, like plastic food containers, parents can also stop putting plastics in the microwave oven and use glass alternatives whenever possible. Phthalate-free cosmetics and personal care products are also available.

This research project was supported by grants from the U.S. Environmental Protection Agency, the National Institutes of Health, and the National Institute of Environmental Health Sciences. The project included researchers from the UW Departments of Occupational and Environmental Health Sciences, Pediatrics, and Biostatistics; the Seattle Children's Hospital Research Institute; the Centers for Disease Control and Prevention; and the University of Rochester School of Medicine and Dentistry.

Adapted from materials provided by University Of Washington.



Read the rest of this entry »

Daily Science Journal (Feb. 9, 2008) — A new energy-capturing knee brace can generate enough electricity from walking to operate a portable GPS locator, a cell phone, a motorized prosthetic joint or an implanted neurotransmitter, research involving the University of Michigan shows.

The biomechanical energy harvester includes an aluminum chassis and generator mounted on a customized orthopaedic knee brace. The device weighs 3.5 lbs. (Credit: Greg Ehlers/Simon Fraser University)

The wearable mechanism works much like regenerative braking charges a battery in some hybrid vehicles, said Arthur Kuo, an associate professor of mechanical engineering at U-M and an author of the paper.*

Regenerative brakes collect the kinetic energy that would otherwise be dissipated as heat when a car slows down. This knee brace harvests the energy lost when a human brakes the knee after swinging the leg forward to take a step.


Kuo, who called the device "a cocktail-napkin idea," says knee joints are uniquely suited for this endeavor.

"There is power to be harvested from various places in the body, and you can use that to generate electricity. The knee is probably the best place," he said. "During walking, you dissipate energy in various places, when your foot hits the ground, for example. You have to make up for this by performing work with your muscles.

"The body is clever," Kuo said. "In a lot of places where it could be dissipating energy, it may actually be storing it and getting it back elastically. Your tendons act like springs. In many places, we're not sure whether the energy is really being dissipated or you're just storing it temporarily. We believe that when you're slowing down the knee at the end of swinging the leg, most of that energy normally is just wasted."

The scientists tested the knee brace on six men walking leisurely on a treadmill at 1.5 meters per second, or 2.2 miles per hour. They measured the subjects' respiration to determine how hard they were working. A control group wore the brace with the generator disengaged to measure how the weight of the 3.5-pound brace affected the wearer.

In the mode in which the brace is only activated while the knee is braking, the subjects required less than one watt of extra metabolic power for each watt of electricity they generated. A typical hand-crank generator, for comparison, takes an average of 6.4 watts of metabolic power to generate one watt of electricity because of inefficiencies of muscles and generators.

"We've demonstrated proof of concept," Kuo said. "The prototype device is bulky and heavy, and it does affect the wearer just to carry. But the energy generation part itself has very little effect on the wearer, whether it is turned on or not. We hope to improve the device so that it is easier to carry, and to retain the energy-harvesting capabilities."

A lighter version would be helpful to hikers or soldiers who don't have easy access to electricity. And the scientists say similar mechanisms could be built into prosthetic knees other implantable devices such as pacemakers or neurotransmitters that today require a battery, and periodic surgery to replace that battery.

"A future energy harvester might be implanted along with such a device and generate its own power from walking," Kuo said.

The paper "Biomechanical Energy Harvesting: Generating Electricity During Walking with Minimal User Effort" is published in the Feb. 8 issue of the journal Science. Authors include researchers from Simon Fraser University in Canada and the University of Pittsburgh, in addition to U-M.

Adapted from materials provided by University of Michigan.



Read the rest of this entry »

Daily Science Journal (Feb. 9, 2008) — Less sleep can increase a child’s risk of being overweight or obese, according to a study by researchers at the Johns Hopkins Bloomberg School of Public Health. Their analysis of epidemiological studies found that with each additional hour of sleep, the risk of a child being overweight or obese dropped by 9 percent.

“Our analysis of the data shows a clear association between sleep duration and the risk for overweight or obesity in children. The risk declined with more sleep,” said Youfa Wang, MD, PhD, senior author of the study and associate professor with the Bloomberg School’s Center for Human Nutrition. “Desirable sleep behavior may be an important low cost means for preventing childhood obesity and should be considered in future intervention studies. Our findings may also have important implications in societies where children do not have adequate sleep due to the pressure for academic excellence and where the prevalence of obesity is rising, such as in many East Asian countries.”


“The influence of sleep quality on obesity risk is another important area where future research is needed,” added Xiaoli Chen, MD, PhD, the study’s lead author and a former postdoctoral fellow at the Bloomberg School.

For the study, Wang, Chen and colleague May A. Beydoun, also a postdoctoral fellow at the Bloomberg School, reviewed 17 published studies on sleep duration and childhood obesity and they analyzed 11 of them in their meta-analysis.

The recommended amount of daily sleep varied between studies analyzed and with children’s age. It is recommended that children under age 5 should sleep for 11 hours or more per day, children age 5 to10 should sleep for 10 hours or more per day, and children over age 10 should sleep at least 9 hours per day.

The results of the analysis showed that children with the shortest sleep duration had a 92 percent higher risk of being overweight or obese compared to children with longer sleep duration. For children under age 5, shortest sleep duration meant less than 9 hours of sleep per day. For children ages 5 to 10 it meant less than 8 hours of sleep per day and less than 7 hours of sleep per day for children over 10. The association between increased sleep and reduced obesity risk was strongly associated with boys, but not in girls.

The results are published in the February 2008 edition Obesity, the journal of The Obesity Society. “Is Sleep Duration Associated with Childhood Obesity? A Systematic Review and Meta-analysis” was written by Xiaoli Chen, May A. Beydoun and Youfa Wang.

The study was supported in part by the National Institute of Diabetes and Digestive and Kidney Diseases, the U.S. Department of Agriculture and the Johns Hopkins Bloomberg School of Public Health.

Adapted from materials provided by Johns Hopkins University Bloomberg School of Public Health.



Read the rest of this entry »